Trademarkia Logo

Canada

C$
TRYGAPOCE
FORMALIZED

on 8 May 2025

Last Applicant/ Owned by

Ionis Pharmaceuticals, Inc.

2855 Gazelle CourtCarlsbad CA 92010

US

Serial Number

2397599 filed on 16th Apr 2025

TRYGAPOCE

Trademark usage description

pharmaceuticals for treatment of genetic diseases and disorders; pharmaceuticals for treatment of cardiovascular, metabolic, neurological, and inflamm Read More

Classification Information


Class [005]
Pharmaceuticals for treatment of genetic diseases and disorders; pharmaceuticals for treatment of cardiovascular, metabolic, neurological, and inflammatory diseases and disorders.


Classification kind code

12

Class [041]
Education and training services, namely, seminars, providing non-downloadable webinars, and workshops for healthcare professionals, caregivers, patients, and providers in the field of genetic diseases and disorders, online journals, namely, blogs featuring information on genetic diseases and disorders; education and training services, namely, seminars, providing non-downloadable webinars, and workshops for healthcare professionals, caregivers, patients, and providers in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders, online journals, namely, blogs featuring information on diseases and disorders of the cardiovascular, metabolic, neurological and inflammatory diseases and disorders.


Classification kind code

12

Class [042]
Pharmaceutical research and development in the field of genetic diseases and disorders, providing medical and scientific research and medical and scientific research information in the field of genetic diseases and disorders, research in the field of genetic diseases and disorders; pharmaceutical research and development in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders, providing medical and scientific research and medical and scientific research information in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders, research in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders.


Classification kind code

12

Class [044]
Medical services; medical information services; providing medical and healthcare information via a website for healthcare professionals, caregivers, patients, and providers in the field of genetic diseases and disorders; medical consulting services in the field of genetic diseases and disorders; healthcare services, namely, providing medical and healthcare information via an online database in the field of genetic diseases and disorders; providing medical and healthcare information concerning the screening, diagnosis, and treatment of genetic diseases and disorders; providing medical and healthcare information via a website for healthcare professionals, caregivers, patients, and providers in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders; medical consulting services in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders; healthcare services, namely, providing medical and healthcare information via an online database in the field of cardiovascular, metabolic, neurological and inflammatory diseases and disorders; providing medical and healthcare information concerning the screening, diagnosis, and treatment of cardiovascular, metabolic, neurological and inflammatory diseases and disorders.


Classification kind code

12

Mark Details


Serial Number

2397599

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 257
on 8th May 2025
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 8th May 2025
Created
Submitted for opposition 31
on 8th May 2025
Formalized
Submitted for opposition 30
on 16th Apr 2025
Filed
Submitted for opposition 228
on 15th Apr 2024
International Registration